StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences capital expenditures ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, FY2025
563
Period ended Dec 31, 2025
Change on a year earlier
+7.6%
523 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCapital expenditures ($M) ($M)Year on yearSource
FY2025Dec 31, 2025563+7.6%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 2024523-10.6%Form 10-K (filed 2025-02-28) ↗
FY2023Dec 31, 2023585-19.6%Form 10-K (filed 2024-02-23) ↗
FY2022Dec 31, 2022728+25.7%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 2021579-10.9%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 2020650-21.2%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 2019825-10.7%Form 10-K (filed 2020-02-25) ↗
FY2018Dec 31, 2018924+56.6%Form 10-K (filed 2019-02-26) ↗
FY2017Dec 31, 2017590-21.1%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 2016748+0.1%Form 10-K (filed 2017-02-27) ↗
FY2015Dec 31, 2015747+34.1%Form 10-K (filed 2016-02-24) ↗
FY2014Dec 31, 2014557+193.2%Form 10-K (filed 2015-02-25) ↗
FY2013Dec 31, 2013190-52.1%Form 10-K (filed 2015-02-25) ↗
FY2012Dec 31, 2012397+201.0%Form 10-K (filed 2015-02-25) ↗
FY2011Dec 31, 2011132+113.1%Form 10-K (filed 2012-02-23) ↗
FY2010Dec 31, 201061.9-73.1%Form 10-K (filed 2011-02-28) ↗

Cite this data

StockData. (2026). Gilead Sciences Capital expenditures ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_capex

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.